Literature DB >> 421557

Isoniazid-induced fever.

J F Dasta, J A Prior, S Kurzrok.   

Abstract

A 56-year-old man was started on therapy with isoniazid after exhibiting a positive reaction to an intradermal injection of intermediate-strength purified protein derivative of tuberculin. After the first dose and each of the following three doses, nausea, vomiting, chills, and an elevated body temperature ranging from 38 degrees C (100.4 degrees F) to 40 degrees C (104. degrees F) occurred. There was no evidence of a hypersensitivity reaction to isoniazid, such as cutaneous rash, eosinophilia, elevated concentration of IgE, and abnormal results on tests of hepatic function. Following discontinuance of therapy with isoniazid, the temperature returned to normal. This experience illustrates the potential of isoniazid to cause febrile reactions, a situation that could be misdiagnosed as an infectious process.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 421557     DOI: 10.1378/chest.75.2.196

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Suppression of prolonged fever during treatment of pulmonary tuberculosis: importance of using twice versus single daily dose of prednisolone.

Authors:  K F Chung; P D Snashall
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

Review 2.  Age-related changes in the manifestations of tuberculosis. Implications for drug therapy.

Authors:  S Umeki
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

3.  Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study.

Authors:  Justin T Denholm; Emma S McBryde; Damon P Eisen; Jocelyn S Penington; Caroline Chen; Alan C Street
Journal:  Drug Healthc Patient Saf       Date:  2014-10-20

4.  Isoniazid-induced flu-like syndrome: A rare side effect.

Authors:  Sudipta Pandit; Sabyasachi Choudhury; Anirban Das; Samadarshi Datta; Sibes K Das
Journal:  Lung India       Date:  2013-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.